Venus Concept Receives FDA 510(k) Clearance of Venus BlissMAX
Venus Concept Inc announces it has received 510(k) clearance from the US Food and Drug Administration to market the Venus BlissMAX device in the United States.
Venus Concept Inc announces it has received 510(k) clearance from the US Food and Drug Administration to market the Venus BlissMAX device in the United States.
Surgeons at Delray Medical Center have published early clinical experience with SMART, a scaffold-based reconstructive technique designed for selected complete muscle transection injuries where suturing alone may be mechanically unreliable. Published in PRS Global Open, the report describes six cases with no construct failures or wound complications reported during available follow-up.